The Combination of Isatuximab with Pomalidomide and Dexamethasone in Second Line Relapse and Refractory Multiple Myeloma

被引：0

作者：

Bobin, Arthur ^{[1
]}

Soufyane, Ennebet ^{[2
]}

Guidez, Stephanie ^{[3
]}

Chacon, Aurelia ^{[4
]}

Gardeney, Helene ^{[5
]}

Basle, Caroline ^{[6
]}

Dindinaud, Elodie ^{[7
]}

Douma, Soukaina ^{[7
]}

Roul, Christophe ^{[8
]}

Corby, Anne ^{[8
]}

Motard, Carine ^{[9
]}

Olivier, Gaelle ^{[9
]}

Denis, Guillaume ^{[10
]}

Vinson, Camille ^{[2
]}

Tomowiak, Cecile ^{[1
]}

Gruchet, Cecile ^{[4
]}

Moya, Niels ^{[1
]}

Mocquot, Pauline ^{[7
]}

Dessane, Berangere ^{[7
]}

Boscagli, Annick ^{[11
]}

Perrot, Aurore ^{[12
]}

Leleu, Xavier ^{[13
,14
,15
]}

机构：

[1] Univ Hosp Poitiers, Dept Anat, Poitiers, France

[2] IUCT Oncopole, Toulouse, France

[3] Univ Hosp Poitiers, Dept Cytol, Poitiers, France

[4] Univ Hosp Poitiers, Dept Anat, Poitiers, France

[5] Univ Hosp Poitiers, Hematol Dept & CIC 1402, Poitiers, France

[6] Univ Hosp Poitiers, Serv Hematol Biol, Poitiers, France

[7] CHU Poitiers, Poitiers, France

[8] CH La Rochelle, La Rochelle, France

[9] CH Niort, Niort, France

[10] Rochefort Hosp, F-59037 Rochefort, France

[11] CH Royan, Royan, France

[12] Univ Toulouse, CHU Toulouse, IUCT O, UPS,Serv Hematol, Toulouse, France

[13] CHU Poitiers, Hop La Miletrie, Poitiers, France

[14] CHU, Serv Hematol & Therapie Cellulaire, Poitiers, France

[15] CIC Inserm 1402, Poitiers, France

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-210687

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7041 / 7042

页数：2

共 50 条

[1] Combination of ixazomib, pomalidomide and dexamethasone in the treatment of multiple myeloma in relapse and refractory to lenalidomide
Stocker, Nicolas
HEMATOLOGIE, 2018, 24 (04): : 261 - 262
[2] Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma
Richardson, Paul G.
Facon, Thierry
Bensinger, William I.
Leleu, Xavier
Campana, Frank
Mace, Sandrine
Chiron, Marielle
van de Velde, Helgi
Mikhael, Joseph
BLOOD CANCER JOURNAL, 2021, 11 (03)
[3] EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma
Delgado, Julio
Zienowicz, Malgorzata
van Hennik, Paula Boudewina
Moreau, Alexandre
Gisselbrecht, Christian
Enzmann, Harald
Pignatti, Francesco
ONCOLOGIST, 2021, 26 (11): : 983 - 987
[4] Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma
Paul G. Richardson
Thierry Facon
William I. Bensinger
Xavier Leleu
Frank Campana
Sandrine Macé
Marielle Chiron
Helgi van de Velde
Joseph Mikhael
Blood Cancer Journal, 11
[5] An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma
Piggin, Anna
Prince, H. Miles
EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (05) : 419 - 427
[6] Preliminary Results from a Phase Ib Study of Isatuximab in Combination with Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Richardson, Paul G.
Mikhael, Joseph
Usmani, Saad Z.
Raje, Noopur
Bensinger, William
Campana, Frank
Gao, Lei
Dubin, Franck
Wack, Claudine
Anderson, Kenneth C.
BLOOD, 2016, 128 (22)
[7] Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan
Nami Tagami
Michihiro Uchiyama
Kenshi Suzuki
Heigoroh Shirai
Takeshi Seto
Shinsuke Iida
International Journal of Hematology, 2025, 121 (4) : 476 - 482
[8] Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma
Hussain, M. Junaid
Robinson, Myra M.
Hamadeh, Issam
Arnall, Justin
Bhutani, Manisha
Atrash, Shebli
Friend, Reed
Pineda-Roman, Mauricio
Symanowski, James T.
Usmani, Saad Z.
Voorhees, Peter M.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (01) : 140 - 144
[9] Pomalidomide in combination with dexamethasone approved for use in refractory multiple myeloma
Brown, Emily
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2013, 2 (06) : 516 - 517
[10] Pomalidomide in combination with dexamethasone approved for use in refractory multiple myeloma
Brown, Emily
FUTURE ONCOLOGY, 2013, 9 (11) : 1684 - 1685

← 1 2 3 4 5 →